Literature DB >> 22648288

Coronary CT angiography after stress testing: an efficient use of resources? Implications of the Advanced Cardiovascular Imaging Consortium (ACIC) results.

Kavitha M Chinnaiyan, Gilbert L Raff, Karthik Ananthasubramaniam.   

Abstract

Coronary CT angiography (CCTA) has matured to be a fast noninvasive imaging test in the evaluation of coronary artery disease (CAD). It has demonstrated excellent accuracy for defining the presence and the severity of luminal coronary artery stenoses and is probably the best noninvasive test to reliably exclude atherosclerotic coronary disease. Furthermore, accumulating CCTA data indicate that it can identify individuals at risk for all-cause mortality. It is also well known that despite the wealth of data regarding diagnostic and prognostic values of stress testing in CAD, up to 10% of stress imaging studies are considered inconclusive, leading to subsequent invasive coronary angiography for definitive diagnosis often with negative results. Moreover, recent data indicate that up to 30 % of patients undergoing angiography have no significant CAD despite a majority of them having had a prior stress test. Whether CCTA can serve as a cost-effective methodology to invasive angiography has been a source of active research. In this context, we will discuss the implications of the recently published data from the Advanced Cardiovascular Imaging Consortium registry looking at the use of CCTA after stress testing in Michigan.

Entities:  

Mesh:

Year:  2012        PMID: 22648288     DOI: 10.1007/s12350-012-9578-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  31 in total

1.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.

Authors:  Nico H J Pijls; William F Fearon; Pim A L Tonino; Uwe Siebert; Fumiaki Ikeno; Bernhard Bornschein; Marcel van't Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; Bernard De Bruyne
Journal:  J Am Coll Cardiol       Date:  2010-05-28       Impact factor: 24.094

2.  ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance.

Authors:  Allen J Taylor; Manuel Cerqueira; John McB Hodgson; Daniel Mark; James Min; Patrick O'Gara; Geoffrey D Rubin; Christopher M Kramer; Daniel Berman; Alan Brown; Farooq A Chaudhry; Ricardo C Cury; Milind Y Desai; Andrew J Einstein; Antoinette S Gomes; Robert Harrington; Udo Hoffmann; Rahul Khare; John Lesser; Christopher McGann; Alan Rosenberg; Robert Schwartz; Marc Shelton; Gerald W Smetana; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2010-11-23       Impact factor: 24.094

3.  Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.

Authors:  Rita F Redberg
Journal:  Health Aff (Millwood)       Date:  2007 Jan-Feb       Impact factor: 6.301

4.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.

Authors:  Nico H J Pijls; Pepijn van Schaardenburgh; Ganesh Manoharan; Eric Boersma; Jan-Willem Bech; Marcel van't Veer; Frits Bär; Jan Hoorntje; Jacques Koolen; William Wijns; Bernard de Bruyne
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

5.  Appropriate use of cardiac computed tomography: applying the yardstick to clinical practice.

Authors:  Prashant Kaul; Manesh R Patel
Journal:  J Cardiovasc Comput Tomogr       Date:  2008-10-29

6.  Health insurers and medical-imaging policy--a work in progress.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

Review 7.  Cardiovascular imaging research at the crossroads.

Authors:  Leslee J Shaw; James K Min; Rory Hachamovitch; Eric D Peterson; Robert C Hendel; Pamela K Woodard; Daniel S Berman; Pamela S Douglas
Journal:  JACC Cardiovasc Imaging       Date:  2010-03

8.  Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography.

Authors:  Naser Ahmadi; Vahid Nabavi; Fereshteh Hajsadeghi; Ferdinand Flores; William J French; Song S Mao; David Shavelle; Ramin Ebrahimi; Matthew Budoff
Journal:  Am J Cardiol       Date:  2011-01       Impact factor: 2.778

9.  Predictive value of exercise stress testing in a family medicine population.

Authors:  Robert J Newman; Mark Darrow; Doyle M Cummings; Valerie King; Lauren Whetstone; Suzanne Kelly; Eric Jalonen
Journal:  J Am Board Fam Med       Date:  2008 Nov-Dec       Impact factor: 2.657

10.  Finding value in imaging: what is appropriate?

Authors:  Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2008 Mar-Apr       Impact factor: 3.872

View more
  2 in total

1.  CT coronary angiography at an ultra-low radiation dose (<0.1 mSv): feasible and viable in times of constraint on healthcare costs.

Authors:  Filippo Cademartiri; Erica Maffei; Teresa Arcadi; Onofrio Catalano; Massimo Midiri
Journal:  Eur Radiol       Date:  2013-01-24       Impact factor: 5.315

2.  Diagnostic yield and accuracy of coronary CT angiography after abnormal nuclear myocardial perfusion imaging.

Authors:  Felix G Meinel; U Joseph Schoepf; Jacob C Townsend; Brian A Flowers; Lucas L Geyer; Ullrich Ebersberger; Aleksander W Krazinski; Wolfgang G Kunz; Kolja M Thierfelder; Deborah W Baker; Ashan M Khan; Valerian L Fernandes; Terrence X O'Brien
Journal:  Sci Rep       Date:  2018-06-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.